The Caribbean Public Health Agency (CARPHA) has cautioned Ministries of Health across the region against administering any dosage of the adult Pfizer-BioNTech COVID-19 vaccine to children aged 5 to 11 years, as they continue to roll out their vaccination campaigns.
Programme Manager, CARPHA Caribbean Regulatory System (CARPHA-CRS) Dr. Rian Extavour said in a statement on Wednesday that although the regional health agency recognizes that uptake of the vaccine is critical to achieving maximum protection from severe disease and death, there is an absence of information on testing of the adult formulation in children 5-11 years.
Also of great concern, Dr. Extavour said, is the increased possibility of errors in administration with drawing up smaller volumes than 0.3mL which is the adult dose, from the adult formulation.
At this time, CARPHA-CRS has not yet recommended the paediatric formulation of the Pfizer vaccine due to the absence of confirmation of the new formulation by the WHO prequalification team under the relevant Emergency Use Listing (EUL).
“Unless otherwise specified, Member States should continue adherence to recommendations for approved vaccines. This will help to ensure favourable benefits to individuals and communities,” Dr. St. John reiterated.
Griffith 5th in 400m hurdles final
Paddon leading Sol Rally Barbados 2023
Concern over decline in number of Bridgetown businesses